213 related articles for article (PubMed ID: 17407804)
1. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.
Bartzokis G; Lu PH; Nuechterlein KH; Gitlin M; Doi C; Edwards N; Lieu C; Altshuler LL; Mintz J
Schizophr Res; 2007 Jul; 93(1-3):13-22. PubMed ID: 17407804
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.
Bartzokis G; Lu PH; Stewart SB; Oluwadara B; Lucas AJ; Pantages J; Pratt E; Sherin JE; Altshuler LL; Mintz J; Gitlin MJ; Subotnik KL; Nuechterlein KH
Schizophr Res; 2009 Sep; 113(2-3):322-31. PubMed ID: 19616412
[TBL] [Abstract][Full Text] [Related]
3. Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.
Bartzokis G; Lu PH; Amar CP; Raven EP; Detore NR; Altshuler LL; Mintz J; Ventura J; Casaus LR; Luo JS; Subotnik KL; Nuechterlein KH
Schizophr Res; 2011 Oct; 132(1):35-41. PubMed ID: 21767934
[TBL] [Abstract][Full Text] [Related]
4. Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.
Bartzokis G; Lu PH; Raven EP; Amar CP; Detore NR; Couvrette AJ; Mintz J; Ventura J; Casaus LR; Luo JS; Subotnik KL; Nuechterlein KH
Schizophr Res; 2012 Sep; 140(1-3):122-8. PubMed ID: 22809684
[TBL] [Abstract][Full Text] [Related]
5. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics.
Tishler TA; Bartzokis G; Lu PH; Raven EP; Khanoyan M; Kirkpatrick CJ; Pyle MH; Villablanca JP; Altshuler LL; Mintz J; Ventura J; Casaus LR; Subotnik KL; Nuechterlein KH; Ellingson BM
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):454-462. PubMed ID: 29735155
[TBL] [Abstract][Full Text] [Related]
7. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
Honey GD; Bullmore ET; Soni W; Varatheesan M; Williams SC; Sharma T
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13432-7. PubMed ID: 10557338
[TBL] [Abstract][Full Text] [Related]
8. Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.
Conley RR; Kelly DL; Nelson MW; Richardson CM; Feldman S; Benham R; Steiner P; Yu Y; Khan I; McMullen R; Gale E; Mackowick M; Love RC
Clin Neuropharmacol; 2005; 28(4):163-8. PubMed ID: 16062094
[TBL] [Abstract][Full Text] [Related]
9. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
11. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
[TBL] [Abstract][Full Text] [Related]
12. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
13. Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.
Kumari V; Ettinger U; Lee SE; Deuschl C; Anilkumar AP; Schmechtig A; Corr PJ; Ffytche DH; Williams SC
Psychopharmacology (Berl); 2015 Sep; 232(17):3135-47. PubMed ID: 25980483
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
15. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
[TBL] [Abstract][Full Text] [Related]
16. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
17. Sexual side effects of novel antipsychotic medications.
Wirshing DA; Pierre JM; Marder SR; Saunders CS; Wirshing WC
Schizophr Res; 2002 Jul; 56(1-2):25-30. PubMed ID: 12084416
[TBL] [Abstract][Full Text] [Related]
18. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
[TBL] [Abstract][Full Text] [Related]
19. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
[TBL] [Abstract][Full Text] [Related]
20. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
